vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and KIRBY CORP (KEX). Click either name above to swap in a different company.

KIRBY CORP is the larger business by last-quarter revenue ($844.1M vs $487.7M, roughly 1.7× CLOVER HEALTH INVESTMENTS, CORP.). KIRBY CORP runs the higher net margin — 9.6% vs -10.1%, a 19.7% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 7.4%). KIRBY CORP produced more free cash flow last quarter ($49.4M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 1.2%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Kirby Corporation, headquartered in Houston, Texas, is the largest tank barge operator in the United States, transporting bulk liquid products throughout the Mississippi River System, on the Gulf Intracoastal Waterway, along all three U.S. Coasts, and in Alaska and Hawaii. Products transported by Kirby include petrochemicals, black oil, refined petroleum products, and agricultural chemical products by tank barge. Kirby also owns and operates eight ocean-going barge and tug units transporting ...

CLOV vs KEX — Head-to-Head

Bigger by revenue
KEX
KEX
1.7× larger
KEX
$844.1M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+37.3% gap
CLOV
44.7%
7.4%
KEX
Higher net margin
KEX
KEX
19.7% more per $
KEX
9.6%
-10.1%
CLOV
More free cash flow
KEX
KEX
$118.4M more FCF
KEX
$49.4M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
1.2%
KEX

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CLOV
CLOV
KEX
KEX
Revenue
$487.7M
$844.1M
Net Profit
$-49.3M
$81.3M
Gross Margin
Operating Margin
-10.1%
12.8%
Net Margin
-10.1%
9.6%
Revenue YoY
44.7%
7.4%
Net Profit YoY
-123.2%
6.6%
EPS (diluted)
$1.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
KEX
KEX
Q1 26
$844.1M
Q4 25
$487.7M
$851.8M
Q3 25
$496.6M
$871.2M
Q2 25
$477.6M
$855.5M
Q1 25
$462.3M
$785.7M
Q4 24
$337.0M
$802.3M
Q3 24
$331.0M
$831.1M
Q2 24
$356.3M
$824.4M
Net Profit
CLOV
CLOV
KEX
KEX
Q1 26
$81.3M
Q4 25
$-49.3M
$91.8M
Q3 25
$-24.4M
$92.5M
Q2 25
$-10.6M
$94.3M
Q1 25
$-1.3M
$76.0M
Q4 24
$-22.1M
$42.8M
Q3 24
$-9.2M
$90.0M
Q2 24
$7.4M
$83.9M
Gross Margin
CLOV
CLOV
KEX
KEX
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Operating Margin
CLOV
CLOV
KEX
KEX
Q1 26
12.8%
Q4 25
-10.1%
15.2%
Q3 25
-4.9%
14.8%
Q2 25
-2.2%
15.4%
Q1 25
-0.3%
13.4%
Q4 24
-6.4%
6.3%
Q3 24
-2.7%
15.3%
Q2 24
2.0%
14.6%
Net Margin
CLOV
CLOV
KEX
KEX
Q1 26
9.6%
Q4 25
-10.1%
10.8%
Q3 25
-4.9%
10.6%
Q2 25
-2.2%
11.0%
Q1 25
-0.3%
9.7%
Q4 24
-6.6%
5.3%
Q3 24
-2.8%
10.8%
Q2 24
2.1%
10.2%
EPS (diluted)
CLOV
CLOV
KEX
KEX
Q1 26
$1.50
Q4 25
$1.68
Q3 25
$1.65
Q2 25
$1.67
Q1 25
$1.33
Q4 24
$0.74
Q3 24
$1.55
Q2 24
$1.43

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
KEX
KEX
Cash + ST InvestmentsLiquidity on hand
$78.3M
$58.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$3.4B
Total Assets
$541.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
KEX
KEX
Q1 26
$58.0M
Q4 25
$78.3M
$78.8M
Q3 25
$47.0M
Q2 25
$68.4M
Q1 25
$51.1M
Q4 24
$194.5M
$74.4M
Q3 24
$288.0M
$67.1M
Q2 24
$254.8M
$53.5M
Total Debt
CLOV
CLOV
KEX
KEX
Q1 26
Q4 25
$919.3M
Q3 25
$1.0B
Q2 25
$1.1B
Q1 25
$1.1B
Q4 24
$874.9M
Q3 24
$978.6M
Q2 24
$1.0B
Stockholders' Equity
CLOV
CLOV
KEX
KEX
Q1 26
$3.4B
Q4 25
$308.7M
$3.4B
Q3 25
$340.9M
$3.4B
Q2 25
$344.2M
$3.4B
Q1 25
$336.1M
$3.3B
Q4 24
$341.1M
$3.4B
Q3 24
$342.2M
$3.3B
Q2 24
$324.9M
$3.3B
Total Assets
CLOV
CLOV
KEX
KEX
Q1 26
Q4 25
$541.0M
$6.0B
Q3 25
$559.7M
$6.1B
Q2 25
$575.0M
$6.1B
Q1 25
$583.7M
$6.0B
Q4 24
$580.7M
$5.9B
Q3 24
$653.0M
$5.9B
Q2 24
$674.2M
$5.9B
Debt / Equity
CLOV
CLOV
KEX
KEX
Q1 26
Q4 25
0.27×
Q3 25
0.31×
Q2 25
0.33×
Q1 25
0.33×
Q4 24
0.26×
Q3 24
0.30×
Q2 24
0.32×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
KEX
KEX
Operating Cash FlowLast quarter
$-66.9M
$97.7M
Free Cash FlowOCF − Capex
$-69.0M
$49.4M
FCF MarginFCF / Revenue
-14.1%
5.9%
Capex IntensityCapex / Revenue
0.4%
5.7%
Cash ConversionOCF / Net Profit
1.20×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$497.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
KEX
KEX
Q1 26
$97.7M
Q4 25
$-66.9M
$312.2M
Q3 25
$12.1M
$227.5M
Q2 25
$5.4M
$93.9M
Q1 25
$-16.3M
$36.5M
Q4 24
$34.8M
$247.4M
Q3 24
$50.0M
$206.5M
Q2 24
$44.8M
$179.3M
Free Cash Flow
CLOV
CLOV
KEX
KEX
Q1 26
$49.4M
Q4 25
$-69.0M
$265.2M
Q3 25
$11.4M
$160.3M
Q2 25
$4.8M
$22.4M
Q1 25
$-16.5M
$-42.1M
Q4 24
$33.3M
$150.7M
Q3 24
$49.6M
$130.1M
Q2 24
$44.4M
$90.8M
FCF Margin
CLOV
CLOV
KEX
KEX
Q1 26
5.9%
Q4 25
-14.1%
31.1%
Q3 25
2.3%
18.4%
Q2 25
1.0%
2.6%
Q1 25
-3.6%
-5.4%
Q4 24
9.9%
18.8%
Q3 24
15.0%
15.7%
Q2 24
12.5%
11.0%
Capex Intensity
CLOV
CLOV
KEX
KEX
Q1 26
5.7%
Q4 25
0.4%
5.5%
Q3 25
0.1%
7.7%
Q2 25
0.1%
8.4%
Q1 25
0.0%
10.0%
Q4 24
0.5%
12.0%
Q3 24
0.1%
9.2%
Q2 24
0.1%
10.7%
Cash Conversion
CLOV
CLOV
KEX
KEX
Q1 26
1.20×
Q4 25
3.40×
Q3 25
2.46×
Q2 25
1.00×
Q1 25
0.48×
Q4 24
5.78×
Q3 24
2.30×
Q2 24
6.04×
2.14×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

KEX
KEX

Marine transportation$497.2M59%
Distribution and services$346.9M41%

Related Comparisons